MIR8076

Across TCGA pan-cancer cohorts, MIR8076 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR8076 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR8076 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR8076 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

THCA, HNSC, and STAD are the cancer types where MIR8076 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	II,III,IV	0.763	0.913	<.001	81	view →
HNSC	OS	Tertile	All	0.495	0.774	.001	66	view →
STAD	DFS	Tertile	IV	0.206	0.534	.002	45	view →
KIRC	DFS	Tertile	IV	0.314	0.627	.023	18	view →
LUAD	DFS	Tertile	II,III,IV	0.361	0.657	.043	9	view →
LUSC	OS	Tertile	III,IV	0.257	0.548	.046	9	view →
ESCA	OS	Tertile	II,III,IV	0.403	0.919	.008	9	view →
SARC	DFS	Tertile	All	0.096	0.591	.006	9	view →
OV	DFS	Tertile	III,IV	0.654	0.522	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR8076–THCA (DFS)

Open the THCA breakdown →